Guangdong Kanghua Healthcare Group Co., Ltd.

SEHK:3689 Voorraadrapport

Marktkapitalisatie: HK$718.9m

Guangdong Kanghua Healthcare Group Beheer

Beheer criteriumcontroles 4/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Wangzhi Chen

Algemeen directeur

CN¥1.5m

Totale compensatie

Percentage CEO-salaris85.7%
Dienstverband CEO8.9yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijn8.4yrs
Gemiddelde ambtstermijn bestuur8.9yrs

Recente managementupdates

Shareholders May Find It Hard To Justify Increasing Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) CEO Compensation For Now

Jun 19
Shareholders May Find It Hard To Justify Increasing Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) CEO Compensation For Now

Key Things To Understand About Guangdong Kanghua Healthcare's (HKG:3689) CEO Pay Cheque

Dec 14
Key Things To Understand About Guangdong Kanghua Healthcare's (HKG:3689) CEO Pay Cheque

Recent updates

There May Be Some Bright Spots In Guangdong Kanghua Healthcare Group's (HKG:3689) Earnings

Sep 30
There May Be Some Bright Spots In Guangdong Kanghua Healthcare Group's (HKG:3689) Earnings

Shareholders May Find It Hard To Justify Increasing Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) CEO Compensation For Now

Jun 19
Shareholders May Find It Hard To Justify Increasing Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) CEO Compensation For Now

Does Guangdong Kanghua Healthcare (HKG:3689) Deserve A Spot On Your Watchlist?

Jun 10
Does Guangdong Kanghua Healthcare (HKG:3689) Deserve A Spot On Your Watchlist?

Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) Share Price Boosted 28% But Its Business Prospects Need A Lift Too

May 22
Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) Share Price Boosted 28% But Its Business Prospects Need A Lift Too

Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal

Nov 28
Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal

Returns On Capital Signal Tricky Times Ahead For Guangdong Kanghua Healthcare (HKG:3689)

May 09
Returns On Capital Signal Tricky Times Ahead For Guangdong Kanghua Healthcare (HKG:3689)

Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal

Feb 02
Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal

Here's Why Guangdong Kanghua Healthcare (HKG:3689) Can Manage Its Debt Responsibly

Nov 08
Here's Why Guangdong Kanghua Healthcare (HKG:3689) Can Manage Its Debt Responsibly

Some Investors May Be Worried About Guangdong Kanghua Healthcare's (HKG:3689) Returns On Capital

Sep 06
Some Investors May Be Worried About Guangdong Kanghua Healthcare's (HKG:3689) Returns On Capital

Investors Could Be Concerned With Guangdong Kanghua Healthcare's (HKG:3689) Returns On Capital

May 31
Investors Could Be Concerned With Guangdong Kanghua Healthcare's (HKG:3689) Returns On Capital

Returns On Capital Signal Tricky Times Ahead For Guangdong Kanghua Healthcare (HKG:3689)

Jan 25
Returns On Capital Signal Tricky Times Ahead For Guangdong Kanghua Healthcare (HKG:3689)

Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal

Sep 21
Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal

Is Guangdong Kanghua Healthcare (HKG:3689) Using Too Much Debt?

May 03
Is Guangdong Kanghua Healthcare (HKG:3689) Using Too Much Debt?

Do Insiders Own Lots Of Shares In Guangdong Kanghua Healthcare Co., Ltd. (HKG:3689)?

Feb 04
Do Insiders Own Lots Of Shares In Guangdong Kanghua Healthcare Co., Ltd. (HKG:3689)?

Key Things To Understand About Guangdong Kanghua Healthcare's (HKG:3689) CEO Pay Cheque

Dec 14
Key Things To Understand About Guangdong Kanghua Healthcare's (HKG:3689) CEO Pay Cheque

Analyse CEO-vergoeding

Hoe is Wangzhi Chen's beloning veranderd ten opzichte van Guangdong Kanghua Healthcare Group's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

CN¥51m

Mar 31 2024n/an/a

CN¥86m

Dec 31 2023CN¥1mCN¥1m

CN¥121m

Sep 30 2023n/an/a

CN¥118m

Jun 30 2023n/an/a

CN¥115m

Mar 31 2023n/an/a

CN¥87m

Dec 31 2022CN¥2mCN¥1m

CN¥60m

Sep 30 2022n/an/a

CN¥59m

Jun 30 2022n/an/a

CN¥59m

Mar 31 2022n/an/a

CN¥76m

Dec 31 2021CN¥2mCN¥1m

CN¥94m

Sep 30 2021n/an/a

CN¥103m

Jun 30 2021n/an/a

CN¥112m

Mar 31 2021n/an/a

CN¥43m

Dec 31 2020CN¥2mCN¥2m

-CN¥25m

Sep 30 2020n/an/a

-CN¥63m

Jun 30 2020n/an/a

-CN¥100m

Mar 31 2020n/an/a

-CN¥13m

Dec 31 2019CN¥2mCN¥2m

CN¥74m

Sep 30 2019n/an/a

CN¥112m

Jun 30 2019n/an/a

CN¥150m

Mar 31 2019n/an/a

CN¥159m

Dec 31 2018CN¥2mCN¥2m

CN¥168m

Sep 30 2018n/an/a

CN¥169m

Jun 30 2018n/an/a

CN¥170m

Mar 31 2018n/an/a

CN¥163m

Dec 31 2017CN¥1mCN¥792k

CN¥157m

Compensatie versus markt: De totale vergoeding ($USD 206.42K ) Wangzhi } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de Hong Kong markt ($USD 235.07K ).

Compensatie versus inkomsten: De vergoeding van Wangzhi is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.


CEO

Wangzhi Chen (53 yo)

8.9yrs

Tenure

CN¥1,470,000

Compensatie

Mr. Wangzhi Chen is Co-Owner of Dongguan Xingda Property Investment Co., Ltd. Mr. Chen serves as Chief Executive Officer of Guangdong Kanghua Healthcare Co., Ltd. Mr. Chen has been Executive Director at Gu...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Junyang Wang
Executive Chairman of the Board8.9yrsCN¥180.00k66.54%
HK$ 478.4m
Wangzhi Chen
CEO & Executive Directorno dataCN¥1.47mgeen gegevens
Wai Hung Wong
Executive Vice Chairman8.9yrsCN¥180.00kgeen gegevens
Aiqin Wang
Executive Directorno dataCN¥303.00kgeen gegevens
Wai Hang Wong
CFO, Joint Company Secretary & Secretary to the Board8.9yrsgeen gegevensgeen gegevens
Baizhi Wang
Vice General Manager of Operation8.4yrsgeen gegevensgeen gegevens
Hing Ling Chau
Joint Company Secretary8.4yrsgeen gegevensgeen gegevens
Li Chen
Financial Controller8.4yrsgeen gegevensgeen gegevens

8.4yrs

Gemiddelde duur

48.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 3689 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 8.4 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Junyang Wang
Executive Chairman of the Board8.9yrsCN¥180.00k66.54%
HK$ 478.4m
Wangzhi Chen
CEO & Executive Director8.9yrsCN¥1.47mgeen gegevens
Wai Hung Wong
Executive Vice Chairman8.9yrsCN¥180.00kgeen gegevens
Aiqin Wang
Executive Director8.9yrsCN¥303.00kgeen gegevens
Keji Chen
Independent Non-Executive Director8.4yrsCN¥120.00kgeen gegevens
Sing Nun Chan
Independent Non-Executive Director8.9yrsCN¥120.00kgeen gegevens
Yubo Lv
Non-Executive Director8.4yrsgeen gegevensgeen gegevens
Ming Lai Yeung
Independent Non-Executive Director8.4yrsCN¥120.00kgeen gegevens
Shaoming Chen
Chairman of the Supervisory Committee8.9yrsgeen gegevensgeen gegevens
Shaofeng Wang
Member of Supervisory Committee8.9yrsgeen gegevensgeen gegevens
Chunyang Yue
Member of Supervisory Committee6.1yrsgeen gegevensgeen gegevens

8.9yrs

Gemiddelde duur

49yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 3689 wordt beschouwd als ervaren (gemiddelde ambtstermijn 8.9 jaar).